Literature DB >> 3877502

Human indolylamine 2,3-dioxygenase. Its tissue distribution, and characterization of the placental enzyme.

F Yamazaki, T Kuroiwa, O Takikawa, R Kido.   

Abstract

The presence of indolylamine 2,3-dioxygenase was examined in human subjects by determining its activity with L-tryptophan as substrate. Enzyme activity was detected in various tissues, and was relatively high in the lung, small intestine and placenta. Human indolylamine 2,3-dioxygenase, partially purified from the placenta, had an Mr of about 40 000 by gel filtration and exhibited a single pI of 6.9. The human enzyme required a reducing system, ascorbic acid and Methylene Blue, for maximal activity and was able to oxidize D-tryptophan, 5-hydroxy-L-tryptophan as well as L-tryptophan, but kinetic studies indicated that the best substrate of the enzyme was L-tryptophan.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877502      PMCID: PMC1152665          DOI: 10.1042/bj2300635

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  14 in total

1.  Indoleamine 2,3-dioxygenase. Characterization and properties of enzyme. O2- complex.

Authors:  F Hirata; T Ohnishi; O Hayaishi
Journal:  J Biol Chem       Date:  1977-07-10       Impact factor: 5.157

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Purification, characterization and identification of rat liver histidine-pyruvate aminotransferase isoenzymes.

Authors:  T Noguchi; E Okuno; Y Minatogawa; R Kido
Journal:  Biochem J       Date:  1976-04-01       Impact factor: 3.857

4.  Indoleamine 2,3-dioxygenase. Purification and some properties.

Authors:  T Shimizu; S Nomiyama; F Hirata; O Hayaishi
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

5.  New degradative routes of 5-hydroxytryptophan and serotonin by intestinal tryptophan 2,3-dioxygenase.

Authors:  F Hirata; O Hayaishi
Journal:  Biochem Biophys Res Commun       Date:  1972-06-09       Impact factor: 3.575

6.  Indoleamine 2,3-dioxygenase. Equilibrium studies of the tryptophan binding to the ferric, ferrous, and CO-bound enzymes.

Authors:  M Sono; T Taniguchi; Y Watanabe; O Hayaishi
Journal:  J Biol Chem       Date:  1980-02-25       Impact factor: 5.157

7.  The gel-filtration behaviour of proteins related to their molecular weights over a wide range.

Authors:  P Andrews
Journal:  Biochem J       Date:  1965-09       Impact factor: 3.857

8.  Tryptophan pyrrolase of rabbit intestine. D- and L-tryptophan-cleaving enzyme or enzymes.

Authors:  S Yamamoto; O Hayaishi
Journal:  J Biol Chem       Date:  1967-11-25       Impact factor: 5.157

9.  Formation of 5-hydroxykynurenine and 5-hydroxykynurenamine from 5-hydroxytryptophan in rabbit small intestine.

Authors:  M Fujiwara; M Shibata; Y Nomiyama; T Sugimoto; F Hirata; T Tokuyama; S Senoh; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

10.  Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection.

Authors:  R Yoshida; Y Urade; M Tokuda; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

View more
  57 in total

1.  Expression of Stat3 and indoleamine 2, 3-dioxygenase in cornea keratocytes as factor of ocular immune privilege.

Authors:  Jae Wook Yang; Dong Sik Ham; Hyun Woong Kim; Sul Gee Lee; Sae Kwang Park; Su Kil Seo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-10       Impact factor: 3.117

Review 2.  α-methyl-L-tryptophan: mechanisms for tracer localization of epileptogenic brain regions.

Authors:  Diane C Chugani
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

3.  Inflammation-induced catabolism of tryptophan and tyrosine in acute ischemic stroke.

Authors:  Heidi Ormstad; Robert Verkerk; Hans Christian D Aass; Karl-Friedrich Amthor; Leiv Sandvik
Journal:  J Mol Neurosci       Date:  2013-08-30       Impact factor: 3.444

Review 4.  Next generation immune-checkpoints for cancer therapy.

Authors:  Chiara Donini; Lorenzo D'Ambrosio; Giovanni Grignani; Massimo Aglietta; Dario Sangiolo
Journal:  J Thorac Dis       Date:  2018-05       Impact factor: 2.895

5.  The role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explants.

Authors:  Y Kudo; C A Boyd
Journal:  J Physiol       Date:  2001-03-01       Impact factor: 5.182

6.  Interferon enhances tryptophan metabolism by inducing pulmonary indoleamine 2,3-dioxygenase: its possible occurrence in cancer patients.

Authors:  H Yasui; K Takai; R Yoshida; O Hayaishi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

7.  Clinical and histopathologic correlates of 11C-alpha-methyl-L-tryptophan (AMT) PET abnormalities in children with intractable epilepsy.

Authors:  Harry T Chugani; Ajay Kumar; William Kupsky; Eishi Asano; Sandeep Sood; Csaba Juhász
Journal:  Epilepsia       Date:  2011-05-13       Impact factor: 5.864

Review 8.  The role of placental tryptophan catabolism.

Authors:  Peter Sedlmayr; Astrid Blaschitz; Roland Stocker
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

Review 9.  The secret life of NAD+: an old metabolite controlling new metabolic signaling pathways.

Authors:  Riekelt H Houtkooper; Carles Cantó; Ronald J Wanders; Johan Auwerx
Journal:  Endocr Rev       Date:  2009-12-09       Impact factor: 19.871

10.  Indoleamine 2,3-dioxygenase: antioxidant enzyme in the human eye.

Authors:  H Z Malina; X D Martin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-07       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.